期刊文献+
共找到7篇文章
< 1 >
每页显示 20 50 100
A Review on the 3D Printing of Functional Structures for Medical Phantoms and Regenerated Tissue and Organ Applications 被引量:10
1
作者 Kan Wang Chia-Che Ho +1 位作者 Chuck Zhang Ben Wang 《Engineering》 SCIE EI 2017年第5期653-662,共10页
Medical models, or "phantoms," have been widely used for medical training and for doctor-patient interactions. They are increasingly used for surgical planning, medical computational models, algorithm verification a... Medical models, or "phantoms," have been widely used for medical training and for doctor-patient interactions. They are increasingly used for surgical planning, medical computational models, algorithm verification and validation, and medical devices development. Such new applications demand high-fidelity, patient-specific, tissue-mimicking medical phantoms that can not only closely emulate the geometric structures of human organs, but also possess the properties and functions of the organ structure. With the rapid advancement of three-dimensional (3D) printing and 3D bioprinting technologies, many researchers have explored the use of these additive manufacturing techniques to fabricate functional medical phantoms for various applications. This paper reviews the applications of these 3D printing and 3D bioprinting technologies for the fabrication of functional medical phantoms and bio-structures. This review specifically discusses the state of the art along with new developments and trends in 3D printed functional medical phantoms (i.e., tissue-mimicking medical phantoms, radiologically relevant medical phantoms, and physiological medical phantoms) and 3D bio-printed structures (i.e., hybrid scaffolding materials, convertible scaffolds, and integrated sensors) for regenerated tissues and organs. 展开更多
关键词 3D printing 3D bioprinting Medical phantom Regenerated tissue/organ scaffold
下载PDF
Novel alternative transplantation therapy for orthotopic liver transplantation in liver failure:A systematic review 被引量:4
2
作者 Tomoaki Furuta Kinji Furuya +1 位作者 Yun-Wen Zheng Tatsuya Oda 《World Journal of Transplantation》 2020年第3期64-78,共15页
BACKGROUND Orthotopic liver transplantation(OLT)is the only treatment for end-stage liver failure;however,graft shortage impedes its applicability.Therefore,studies investigating alternative therapies are plenty.Never... BACKGROUND Orthotopic liver transplantation(OLT)is the only treatment for end-stage liver failure;however,graft shortage impedes its applicability.Therefore,studies investigating alternative therapies are plenty.Nevertheless,no study has comprehensively analyzed these therapies from different perspectives.AIM To summarize the current status of alternative transplantation therapies for OLT and to support future research.METHODS A systematic literature search was performed using PubMed,Cochrane Library and EMBASE for articles published between January 2010 and 2018,using the following MeSH terms:[(liver transplantation)AND cell]OR[(liver transplantation)AND differentiation]OR[(liver transplantation)AND organoid]OR[(liver transplantation)AND xenotransplantation].Various types of studies describing therapies to replace OLT were retrieved for full-text evaluation.Among them,we selected articles including in vivo transplantation.RESULTS A total of 89 studies were selected.There are three principle forms of treatment for liver failure:Xeno-organ transplantation,scaffold-based transplantation,and cell transplantation.Xeno-organ transplantation was covered in 14 articles,scaffold-based transplantation was discussed in 22 articles,and cell transplantation was discussed in 53 articles.Various types of alternative therapies were discussed:Organ liver,25 articles;adult hepatocytes,31 articles;fetal hepatocytes,three articles;mesenchymal stem cells(MSCs),25 articles;embryonic stem cells,one article;and induced pluripotent stem cells,three articles and other sources.Clinical applications were discussed in 12 studies:Cell transplantation using hepatocytes in four studies,five studies using umbilical cord-derived MSCs,three studies using bone marrow-derived MSCs,and two studies using hematopoietic stem cells.CONCLUSION The clinical applications are present only for cell transplantation.Scaffold-based transplantation is a comprehensive treatment combining organ and cell transplantations,which warrants future research to find relev 展开更多
关键词 Cell TRANSPLANTATION Liver TRANSPLANTATION organ TRANSPLANTATION XENOTRANSPLANTATION TISSUE engineering scaffold
下载PDF
肾和肺的去细胞器官支架体外灌注制备方法的优化 被引量:2
3
作者 陈翩翩 林倩 +1 位作者 朱群燕 赵应征 《中国生物医学工程学报》 CAS CSCD 北大核心 2017年第3期380-384,共5页
研究采用体外灌注法制备肾和肺去细胞器官支架的最优方法。将10只成年SD雄鼠作为器官支架供体,进行去细胞器官支架制备,不同器官采用不同血液循环方法进行体外大气压灌注(基于大气压力往循环体系中注入)0.75%SDS、1%Triton X-100、0.1%H... 研究采用体外灌注法制备肾和肺去细胞器官支架的最优方法。将10只成年SD雄鼠作为器官支架供体,进行去细胞器官支架制备,不同器官采用不同血液循环方法进行体外大气压灌注(基于大气压力往循环体系中注入)0.75%SDS、1%Triton X-100、0.1%H_2O_2制备器官去细胞支架,通过HE染色、DAPI荧光染色方法检测去细胞程度,通过扫描电镜观察其结构脉络网和去细胞程度,通过阿利新蓝-过碘酸雪夫氏染法(AB-PAS)、Masson染色、免疫组化染色方法检测去细胞器官支架的成分保留。结果表明,采用体外大气压灌注法制备的去细胞器官支架能有效去除细胞,且糖原、胶原、纤连蛋白(Fibronectin)、弹性蛋白(Elastin)、层粘连蛋白(Laminin)、IV型胶原(Collagen IV)等有效保留,同时支架能保持良好的结构脉络网。通过大气压注入去细胞化试剂,能有效保留良好的结构脉络网,同时达到有效的去细胞程度(去细胞程度大于99%),且营养成分能有效保留。 展开更多
关键词 体外灌注 去细胞化 器官支架
下载PDF
丝素蛋白用于药物释放支架材料的研究进展
4
作者 王群 齐鲁 《生物技术世界》 2015年第11期168-169,共2页
丝素蛋白生物材料具有制备工艺条件温和、力学性能可控、生物相容性好等特点,在组织工程材料等领域中的研究受到广泛关注。文章介绍了丝素蛋白应用在组织工程用药物释放支架材料中的研究进展,并对该领域中有待深入研究的问题进行了总结。
关键词 丝素蛋白 组织工程 药物释放 支架
下载PDF
4种肺脏全器官脱细胞支架制备方法的比较 被引量:1
5
作者 刘芬 董明清 +2 位作者 邢书娟 赵峰 张艰 《生物医学工程与临床》 CAS 2019年第2期121-128,共8页
目的分别采用4种不同的方法灌注大鼠肺脏,采集灌注后肺组织大体形态;采取5种不同的染色方法比较脱细胞后肺组织的变化,筛选出较优的脱细胞方法。方法选择SD大鼠12只,雌雄不限,鼠龄8~9周,体质量200~300 g。随机分成4组[3-[(3-胆酰胺丙... 目的分别采用4种不同的方法灌注大鼠肺脏,采集灌注后肺组织大体形态;采取5种不同的染色方法比较脱细胞后肺组织的变化,筛选出较优的脱细胞方法。方法选择SD大鼠12只,雌雄不限,鼠龄8~9周,体质量200~300 g。随机分成4组[3-[(3-胆酰胺丙基)二甲氨基]丙磺酸内盐(CHAPS)组、乙二胺四乙酸二钠盐(EDTA-2Na)组、十二烷基硫酸钠(SDS)组、冻/融组],每组3只。取出整个大鼠肺,用设定的灌注系统采用0.9%氯化钠溶液(生理盐水)适当冲洗其上血液。采用下述脱细胞方法制备:CHAPS组用浓度8 mmol/L CHAPS灌注,EDTA-2Na组用浓度25 mmol/L EDTA-2Na灌注,SDS组用0.1%SDS灌注,冻/融组先冻融后再用0.1%SDS灌注,灌注完毕后均采用0.9%氯化钠溶液200 m L灌注冲洗,最后对脱细胞肺基质分别进行大体形态拍照、苏木精-伊红(HE)染色、弹性纤维(EVG)染色、masson染色、COL-Ⅰ免疫组织化学染色、COL-Ⅲ免疫组织化学染色。结果 CHAPS组肺组织大体形态最为透明;HE染色可见EDTA-2Na组仍残留较多细胞核成分,其余组未见明显的细胞核成分;各组脱细胞后,肺基质构成的肺泡、细支气管等支架结构基本完整。EVG染色可见SDS组和CHAPS组染色较淡,但是SDS组对微结构破坏较大,CHAPS组肺基质保留较完整;COL-Ⅰ免疫组织化学染色可见CHAPS组肺基质保留较其他组完好;COL-Ⅲ免疫组织化学染色可见:SDS组和冻/融组较CHAPS组染色较深,COL-Ⅲ保留较多,且SDS组同冻/融组深浅无明显差别。masson染色可见:CHAPS组和冻/融组肺胶原纤维保留较完整,SDS组肺胶原纤维破坏较大。结论浓度8 mmol/L CHAPS灌注方法是一种较好的制备肺脏脱细胞支架的方法。 展开更多
关键词 全器官脱细胞 组织工程 细胞外基质 脱细胞支架
下载PDF
Vascularized tissue-engineered adipose established v/a the adipose-derived stem cells-attached scaffolds encapsulated in muscular fasciae with axial pattern blood vessel pedicle
6
《中国组织工程研究》 CAS CSCD 2013年第18期3349-3357,共9页
关键词 摘要 编辑部 编辑工作 读者
下载PDF
纳米技术构建组织工程3D支架研究进展
7
作者 杨俊峰 王尧 史宏灿 《国际外科学杂志》 2015年第8期558-562,共5页
纳米材料由于其优良的机械、化学以及生物兼容性,已经在再生医学领域被广泛应用.由纳米材料制备的人工 3D支架在组织工程应用方面已经取得了一定发展.本文对纳米技术构建3D支架在组织工程中应用进展做一综述,包括纳米材料3D支架的制备... 纳米材料由于其优良的机械、化学以及生物兼容性,已经在再生医学领域被广泛应用.由纳米材料制备的人工 3D支架在组织工程应用方面已经取得了一定发展.本文对纳米技术构建3D支架在组织工程中应用进展做一综述,包括纳米材料3D支架的制备方法以及纳米支架在机械、化学以及生物兼容性、生物降解性等方面的优势. 展开更多
关键词 纳米材料 3D器官支架 组织工程 再生医学 综述
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部